Abstract

Prec-P-01 - Preclinical investigation of new targeted combination therapies in cutaneous T-cell lymphoma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A Role of JAK/STAT Pathway in Cutaneous T-Cell Lymphomas: Exploring Its Effects for Targeted Therapy
Helena Pisonero ... Nerea Martinez
Blood | VOL. 124
Helena Pisonero, et. al.Helena Pisonero ... Nerea Martinez
06 Dec 2014
Novel Approaches For Targeted Therapy In Cutaneous T-Cell Lymphomas
Margarita Sanchez Beato ... Cristina Pérez
Blood | VOL. 122
Margarita Sanchez Beato, et. al.Margarita Sanchez Beato ... Cristina Pérez
15 Nov 2013
Cutaneous T-Cell Lymphoma (CTCL) Cell Line-Derived Extracellular Vesicles Contain HERV-W-Encoded Fusogenic Syncytin-1
Annika Hau ... Annamari Ranki
Journal of Investigative Dermatology | VOL. 140
Annika Hau, et. al.Annika Hau ... Annamari Ranki
26 Dec 2019
ONC201 Induces Apoptosis in Cutaneous T-Cell Lymphoma Cells through a Mechanism That Involves the Integrated Stress Response and Inactivation of Jak/Stat Signaling
Madeleine Duvic ... Josh Allen
Blood | VOL. 126
Madeleine Duvic, et. al.Madeleine Duvic ... Josh Allen
03 Dec 2015
View more papers

More From: European Journal of Cancer

Paper Title
Journal
Date
Author
Editorial Board
-
European Journal of Cancer | VOL. -
--
01 Jun 2024
OpenAI’s GPT-4o in surgical oncology: Revolutionary advances in generative artificial intelligence
Ning Zhu ... Haiyang Wu
European Journal of Cancer | VOL. 206
Ning Zhu, et. al.Ning Zhu ... Haiyang Wu
26 May 2024
A single-arm, multicenter, phase 2 clinical study of recombinant humanized anti-HER2 monoclonal antibody-MMAE conjugate (MRG002) in HER2-positive unresectable locally advanced or metastatic urothelial carcinoma
Wang Qu ... Aiping Zhou
European Journal of Cancer | VOL. 205
Wang Qu, et. al.Wang Qu ... Aiping Zhou
10 May 2024
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial
Pasquale Rescigno ... Johann De Bono
European Journal of Cancer | VOL. 205
Pasquale Rescigno, et. al.Pasquale Rescigno ... Johann De Bono
08 May 2024
View more papers